Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4762

Next 25
Website Changes
02/17/2019 why some brain tumors respond to immunotherapy
02/17/2019 Confirmation of high therapeutic effect in doctor-led clinical trials of viral therapy for brain tumor - Application for approval for the manufacture and marketing of the first cancer treatment viral drug in Japan -
02/15/2019 Statins, NSAIDS Have No Apparent Survival Benefit for Grade IV Glioma
02/14/2019 Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)
02/14/2019 University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors
02/13/2019 Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation
02/13/2019 Progesterone is more effective than dexamethasone in prolonging overall survival and preserving neurologic functions in experimental animals with orthotopic glioblastoma allografts.
02/13/2019 Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.
02/13/2019 Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.
02/13/2019 Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma
02/12/2019 Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
02/12/2019 Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
02/11/2019 Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial
02/10/2019 Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55
02/06/2019 Brain Tumor `Pied Piper` Device Gains Breakthrough Status
02/05/2019 Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for its Brain Tumor Drug
01/31/2019 GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor
01/30/2019 Musella Foundation awards a pediatric brain tumor research grant!
01/26/2019 The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.
01/26/2019 Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells.
01/26/2019 Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.
01/26/2019 Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
01/26/2019 Effect of health disparities on overall survival of patients with glioblastoma.
01/25/2019 New Liquid Biopsy Test Detects Brain Cancer, But It Doesn`t Use Blood
01/23/2019 Regorafenib Doubles 12-Month Survival Compared with Lomustine in Recurrent GBM


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740